We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Bayer and Matsushita in Diagnostic Alliance

By HospiMedica staff writers
Posted on 01 Jun 2001
A long-term strategic business relationship to jointly develop, manufacture, and market diagnostic products has been announced by Bayer Corp. More...
(Tarrytown, NY, USA) and Matsushita Electric Industrial Co. (Osaka, Japan).

Under the agreement, Bayer Corporation, through its Business Group Diagnostics, will acquire rights for the sale and marketing of newly developed products and services for a broad range of applications for the diagnostics market, while Matsushita will be primarily responsible for the development and manufacture of new products and services. Combining Bayer's knowledge of the diagnostics customer and marketplace with the technologic expertise of Matsushita will enable both companies to develop products that meet the needs of the worldwide in vitro diagnostics market, estimated to reach US$25 billion by 2005.

"The relationship will leverage our combined strengths to develop innovative diagnostics solutions that meet the changing needs of the health-care market,” said Rolf Classen, president of Bayer Diagnostics. "We have already begun work on products for blood glucose monitoring through our Self Testing segment in Elkhart, Indiana, and the future opportunities are limitless.”





Related Links:
Bayer
Matsushita

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Thyroid Test
Anti-Thyroid EIA Test
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.